Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.

Thrombosis and haemostasis - 1 Dec 2013

Xu Xiuzhang, Ye Xin, Xia Wenjie, Liu Jing, Ding Haoqiang, Deng Jing, Chen Yangkai, Shao Yuan, Wang Jiali, Fu Yongshui, Santoso Sentot

Abstract excerpt

CD36 (also known as GPIV) deficiency is known to be responsible for the production of anti-Nak(a) antibodies in different clinical settings such as fetal/neonatal alloimmune thrombocytopenia (FNAIT), platelet transfusion refractoriness (PTR) and post-transfusion purpura (PTP). However, no data regarding the relevance of CD36 immunisation is currently available for China. In this study, healthy blood donors were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Antigens, Human Platelet

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Blood Platelets

Share to CD36 Antigens

Share to Cell Separation

Share to Pregnancy Complications

Share to Purpura, Thrombocytopenic, Idiopathic

Share to Transfusion Reaction

Source

Identifiers

PMID: 23966019
DOI: 10.1160/TH13-05-0435

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.PMID 23966019Read ↗

Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness.Semantic proximity Read ↗

Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importanceSemantic proximity Read ↗

Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma.Semantic proximity Read ↗

High-Throughput CD36 Phenotyping on Human Platelets Based on Sandwich ELISA and Mutant Gene AnalysisSemantic proximity Read ↗

Integrating HLA and HPA for Precision Transfusion: Anti-CD36–Mediated Refractoriness and Hemostatic ChallengesSemantic proximity Read ↗

Frequency and molecular basis of CD36 deficiency among platelet donors in Kunming, China.Semantic proximity Read ↗

Incidence and molecular basis of CD36 deficiency in Shanghai population.Semantic proximity Read ↗

Fetal/neonatal alloimmune thrombocytopenia due to anti‐ CD36 antibodies: antibody evaluations by CD36 ‐transfected cell linesSemantic proximity Read ↗

Haplotypes analysis reveals the genetic basis of type I CD36 deficiency.Semantic proximity Read ↗

Integrating HLA and HPA in Precision Transfusion: Insights from Platelet Transfusion Refractoriness Driven by Anti-CD36 Alloimmunization and Multifactorial Hemostatic ComplicationsSemantic proximity Read ↗

CD36 deficiency is frequent and can cause platelet immunization in Africans.Semantic proximity Read ↗

[A novel CD36 mutation T538C (Trp180Arg) results in CD36 deficiency and establishment of a genotyping method for the novel mutation based on sequence-specific primer PCR].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.